| |
|
|
Ahn-Gook Pharmaceutical (001540) |
|
|
KOSDAQ |
|
|
| Address |
993-75, DAERIM 2-DONG, YEONGDEUNGPO-GU, SEOUL |
| Home Page |
www.ahn-gook.com
|
| Established |
1959. 2.12 |
Tel |
02-3289-4200 |
| Listed |
2000. 6.15 |
IR |
02-3289-4226 |
| Common shares O/S |
11,500,000 |
President |
Eo,Jun Seon/Eo,Jin |
| Preferred shares O/S |
|
No.of Employees |
401(2009. 9) |
| Sales increased on rising demand for its key products. Profitability improved on stable revenue structure, although marketing cost increased. The company increased R&D spending, and beefed up its sales of generic drugs. |
| Sales are expected to increase on diversified product mix, and new drug Anycough may help boost sales. Profitability is expected to improve on rising demand for high-priced products. Its new drug, Anycough, is expected to further boost sales. |
|
  |
(date: 2009.06, unit : %) |
| Name |
Eo Junseon |
Eo Jin |
CITIGROUP GLOBAL MARKETS |
| Portion |
30.0 |
17.0 |
6.2 |
|
 |
(unit : %) |
| Sales |
Respiratory Drug |
39.8 |
Cost |
Raw Materials |
|
| Others |
36.7 |
Labors |
|
| Digestive Drug |
13.0 |
Overhead |
|
|
 |
(Unit : 100Mn.Won,Won) |
| Year |
00. 6 |
02. 9 |
- |
- |
- |
| Type |
LI |
SS |
- |
- |
- |
| Amount |
57.50 |
500.00 |
- |
- |
- |
|
|
|
|
